PPARD and Other metabolic disease: Among metabolic modulators of fatty acid metabolism, agonists of the Peroxisome Proliferator-Activated Receptor beta/delta (PPARβ/δ) have been studied this last decade as “endurance-exercise mimetics”, susceptible to becoming therapies for metabolic diseases by increasing skeletal muscle FAO and reducing inflammation [19,20].